Abstract
This study was undertaken to determine whether an enzyme, pancreatic dornase, plus an antibiotic aerosolized for endobronchial application via the intermittent positive pressure breathing/ inspiration machine would be a valuable adjunctive measure to systemic antibiotics in the treatment of pneumonias. Thirty patients with pneumonia have been successfully treated by this method. Half of these patients had staphylococcal pneumonia (some with lung abscesses). Pancreatic dornase was effective in lysing the endobronchial exudate, which became thinner and more easily expelled. Removal of a thickened exudate by this enzyme makes concurrent and subsequent application of an aerosolized antibiotic more effective.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
